{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:12:57Z","timestamp":1787026377506,"version":"build-2736575974"},"reference-count":131,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013-603288-SysVasc"],"award-info":[{"award-number":["FP7\/2007-2013-603288-SysVasc"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["La315-15, AL2054\/1-1, VO2259\/2-1"],"award-info":[{"award-number":["La315-15, AL2054\/1-1, VO2259\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2018.00207","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:25:58Z","timestamp":1525393558000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Therapeutic Interference With Vascular Calcification\u2014Lessons From Klotho-Hypomorphic Mice and Beyond"],"prefix":"10.3389","volume":"9","author":[{"given":"Florian","family":"Lang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Leibrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisann","family":"Pelzl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinrad","family":"Gawaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkert","family":"Pieske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Alesutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Voelkl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"B2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/ATVBAHA.116.306258","article-title":"Arterial calcification in diabetes mellitus: preclinical models and translational implications","volume":"37","author":"Stabley","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1161\/hy1001.096358","article-title":"Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease","volume":"38","author":"Blacher","year":"2001","journal-title":"Hypertension"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/ndt\/gfg414","article-title":"Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality","volume":"18","author":"London","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"B5","first-page":"S16","article-title":"Epidemiology of cardiovascular disease in chronic renal disease","volume":"9","author":"Foley","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"S300","DOI":"10.1097\/01.ASN.0000081663.52165.66","article-title":"Vascular calcification: in vitro evidence for the role of inorganic phosphate","volume":"14","author":"Giachelli","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"B8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1161\/hh2401.101070","article-title":"Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers","volume":"89","author":"Steitz","year":"2001","journal-title":"Circ Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e97565","DOI":"10.1371\/journal.pone.0097565","article-title":"Fetuin-A and albumin alter cytotoxic effects of calcium phosphate nanoparticles on human vascular smooth muscle cells","volume":"9","author":"Dautova","year":"2014","journal-title":"PLoS One"},{"key":"B11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.yjmcc.2017.12.007","article-title":"Calcium phosphate particles stimulate interleukin-1beta release from human vascular smooth muscle cells: a role for spleen tyrosine kinase and exosome release","volume":"115","author":"Dautova","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"F891","DOI":"10.1152\/ajprenal.00163.2014","article-title":"A current understanding of vascular calcification in CKD","volume":"307","author":"Paloian","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000477244","article-title":"Hope for CKD-MBD patients: new diagnostic approaches for better treatment of CKD-MBD","volume":"3","author":"Hocher","year":"2017","journal-title":"Kidney Dis (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/MNH.0000000000000237","article-title":"Novel assessments of systemic calcification propensity","volume":"25","author":"Pasch","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1093\/ndt\/gfw048","article-title":"Fetuin-A-containing calciprotein particles in mineral trafficking and vascular disease","volume":"31","author":"Holt","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B16","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/kisup.2013.88","article-title":"A phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease","volume":"3","author":"Kuro","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00223-012-9690-6","article-title":"The role of fetuin-A in physiological and pathological mineralization","volume":"93","author":"Brylka","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"B18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.tcm.2012.07.020","article-title":"Fetuin-A function in systemic mineral metabolism","volume":"22","author":"Herrmann","year":"2012","journal-title":"Trends Cardiovasc Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1161\/CIRCRESAHA.110.234260","article-title":"Fetuin-A regulation of calcified matrix metabolism","volume":"108","author":"Jahnen-Dechent","year":"2011","journal-title":"Circ Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"6353","DOI":"10.1109\/EMBC.2016.7592181","article-title":"Predicting seizures from local field potentials recorded via intracortical microelectrode arrays","volume":"2016","author":"Aghagolzadeh","year":"2016","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","article-title":"Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification","volume":"98","author":"Li","year":"2006","journal-title":"Circ Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e88646","DOI":"10.1172\/jci.insight.88646","article-title":"Activating transcription factor-4 promotes mineralization in vascular smooth muscle cells","volume":"1","author":"Masuda","year":"2016","journal-title":"JCI Insight"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.108.783738","article-title":"Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis","volume":"118","author":"Shroff","year":"2008","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1172\/JCI24140","article-title":"Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals","volume":"115","author":"Shao","year":"2005","journal-title":"J Clin Invest"},{"key":"B25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.bbrc.2012.04.149","article-title":"SOX9 and myocardin counteract each other in regulating vascular smooth muscle cell differentiation","volume":"422","author":"Xu","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"B26","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/cvr\/cvw205","article-title":"Runx2 deletion in smooth muscle cells inhibits vascular osteochondrogenesis and calcification but not atherosclerotic lesion formation","volume":"112","author":"Lin","year":"2016","journal-title":"Cardiovasc Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.bone.2012.11.032","article-title":"Osmolarity determines the in vitro chondrogenic differentiation capacity of progenitor cells via nuclear factor of activated T-cells 5","volume":"53","author":"Caron","year":"2013","journal-title":"Bone"},{"key":"B28","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jbmr.2420","article-title":"Pathophysiological role of vascular smooth muscle alkaline phosphatase in medial artery calcification","volume":"30","author":"Sheen","year":"2015","journal-title":"J Bone Miner Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1007\/s11914-015-0293-9","article-title":"Pathophysiology of vascular calcification","volume":"13","author":"Chen","year":"2015","journal-title":"Curr Osteoporos Rep"},{"key":"B30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ajpath.2010.10.006","article-title":"Elastin degradation and vascular smooth muscle cell phenotype change precede cell loss and arterial medial calcification in a uremic mouse model of chronic kidney disease","volume":"178","author":"Pai","year":"2011","journal-title":"Am J Pathol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1093\/ndt\/gfp137","article-title":"Arterial calcification in patients with chronic kidney disease","volume":"24","author":"Koleganova","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1681\/ASN.2008070692","article-title":"Vascular calcification: the killer of patients with chronic kidney disease","volume":"20","author":"Mizobuchi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/nrneph.2013.111","article-title":"Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism","volume":"9","author":"Kuro-o","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.bone.2017.01.017","article-title":"Potential application of klotho in human chronic kidney disease","volume":"100","author":"Neyra","year":"2017","journal-title":"Bone"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1681\/ASN.2014040325","article-title":"Soluble klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate","volume":"26","author":"Xie","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000452880","article-title":"Klotho\/FGF23 axis in chronic kidney disease and cardiovascular disease","volume":"3","author":"Lu","year":"2017","journal-title":"Kidney Dis (Basel)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.addr.2017.07.009","article-title":"Effects of klotho on fibrosis and cancer: a renal focus on mechanisms and therapeutic strategies","volume":"121","author":"Mencke","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"B40","doi-asserted-by":"publisher","first-page":"F1171","DOI":"10.1152\/ajprenal.00233.2010","article-title":"Hyperaldosteronism in klotho-deficient mice","volume":"299","author":"Fischer","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/cvr\/cvw062","article-title":"Augmentation of phosphate-induced osteo-\/chondrogenic transformation of vascular smooth muscle cells by homoarginine","volume":"110","author":"Alesutan","year":"2016","journal-title":"Cardiovasc Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1112766","article-title":"Suppression of aging in mice by the hormone klotho","volume":"309","author":"Kurosu","year":"2005","journal-title":"Science"},{"key":"B43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10522-009-9229-z","article-title":"The frequency of klotho KL-VS polymorphism in a large Italian population, from young subjects to centenarians, suggests the presence of specific time windows for its effect","volume":"11","author":"Invidia","year":"2010","journal-title":"Biogerontology"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ki.2012.322","article-title":"Vitamin D receptor agonists increase klotho and osteopontin while decreasing aortic calcification in mice with chronic kidney disease fed a high phosphate diet","volume":"82","author":"Lau","year":"2012","journal-title":"Kidney Int"},{"key":"B45","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1210\/me.2003-0048","article-title":"Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system","volume":"17","author":"Tsujikawa","year":"2003","journal-title":"Mol Endocrinol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.febslet.2011.05.021","article-title":"Regulation of the Na+\/K+ ATPase by klotho","volume":"585","author":"Sopjani","year":"2011","journal-title":"FEBS Lett"},{"key":"B47","doi-asserted-by":"publisher","first-page":"F745","DOI":"10.1152\/ajprenal.00037.2011","article-title":"Downregulation of klotho expression by dehydration","volume":"301","author":"Tang","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bone.2018.02.023","article-title":"Biochemical transformation of calciprotein particles in uraemia","volume":"110","author":"Smith","year":"2018","journal-title":"Bone"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1681\/ASN.2007080902","article-title":"Vitamin D receptor activators can protect against vascular calcification","volume":"19","author":"Mathew","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1681\/ASN.2008121273","article-title":"Klotho prevents renal calcium loss","volume":"20","author":"Alexander","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1093\/ndt\/gfs291","article-title":"Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD?","volume":"27","author":"Kovesdy","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B52","first-page":"103","article-title":"The role of metabolic acidosis in causing uremic hyperphosphatemia","volume":"12","author":"Barsotti","year":"1986","journal-title":"Miner Electrolyte Metab"},{"key":"B53","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/ki.2013.401","article-title":"Bicarbonate therapy for prevention of chronic kidney disease progression","volume":"85","author":"Loniewski","year":"2014","journal-title":"Kidney Int"},{"key":"B54","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1172\/JCI112020","article-title":"Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3","volume":"76","author":"Nath","year":"1985","journal-title":"J Clin Invest"},{"key":"B55","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sj.ki.5002647","article-title":"Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors","volume":"73","author":"Phisitkul","year":"2008","journal-title":"Kidney Int"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ki.2012.267","article-title":"Angiotensin II receptors mediate increased distal nephron acidification caused by acid retention","volume":"82","author":"Wesson","year":"2012","journal-title":"Kidney Int"},{"key":"B57","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1681\/ASN.V551193","article-title":"Renal cystic disease and ammoniagenesis in Han:SPRD rats","volume":"5","author":"Torres","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/sj.ki.5002646","article-title":"Metabolic acidosis inhibits soft tissue calcification in uremic rats","volume":"73","author":"Mendoza","year":"2008","journal-title":"Kidney Int"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1046\/j.1523-1755.2000.00260.x","article-title":"Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease","volume":"58","author":"Jara","year":"2000","journal-title":"Kidney Int"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1093\/ndt\/gfh311","article-title":"Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. I. Renal function and biochemical changes","volume":"19","author":"Jara","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"B61","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1681\/ASN.2014020205","article-title":"Current status of bicarbonate in CKD","volume":"26","author":"Dobre","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"de Brito-Ashurst","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"F102","DOI":"10.1152\/ajprenal.00037.2015","article-title":"Bicarbonate-sensitive calcification and lifespan of klotho-deficient mice","volume":"310","author":"Leibrock","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00109-015-1331-x","article-title":"Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice","volume":"94","author":"Leibrock","year":"2016","journal-title":"J Mol Med (Berl)"},{"key":"B65","first-page":"139","article-title":"Vascular calcification and metabolic acidosis in end stage renal disease","volume":"13","author":"Yonova","year":"2009","journal-title":"Hippokratia"},{"key":"B66","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00424-009-0746-z","article-title":"Compensatory regulation of the sodium\/phosphate cotransporters NaPi-IIc (SCL34A3) and Pit-2 (SLC20A2) during Pi deprivation and acidosis","volume":"459","author":"Villa-Bellosta","year":"2010","journal-title":"Pflugers Arch"},{"key":"B67","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00424-008-0580-8","article-title":"Regulation of phosphate transport in proximal tubules","volume":"458","author":"Biber","year":"2009","journal-title":"Pflugers Arch"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1159\/000362968","article-title":"Up-regulation of hepatic alpha-2-HS-glycoprotein transcription by testosterone via androgen receptor activation","volume":"33","author":"Voelkl","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e68987","DOI":"10.1371\/journal.pone.0068987","article-title":"Osteoprotegerin inhibits calcification of vascular smooth muscle cell via down regulation of the notch1-RBP-Jkappa\/Msx2 signaling pathway","volume":"8","author":"Zhou","year":"2013","journal-title":"PLoS One"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.kint.2015.12.046","article-title":"Osteopontin protects against high phosphate-induced nephrocalcinosis and vascular calcification","volume":"89","author":"Paloian","year":"2016","journal-title":"Kidney Int"},{"key":"B71","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ki.1987.222","article-title":"Serum magnesium level and arterial calcification in end-stage renal disease","volume":"32","author":"Meema","year":"1987","journal-title":"Kidney Int"},{"key":"B72","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1159\/000366124","article-title":"Lower serum magnesium is associated with cardiovascular risk factors and mortality in haemodialysis patients","volume":"38","author":"Jo\u00e3o Matias","year":"2014","journal-title":"Blood Purif"},{"key":"B73","doi-asserted-by":"publisher","first-page":"7419524","DOI":"10.1155\/2016\/7419524","article-title":"Magnesium attenuates phosphate-induced deregulation of a microRNA signature and prevents modulation of Smad1 and osterix during the course of vascular calcification","volume":"2016","author":"Louvet","year":"2016","journal-title":"Biomed Res Int"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e0115342","DOI":"10.1371\/journal.pone.0115342","article-title":"Characterisation of calcium phosphate crystals on calcified human aortic vascular smooth muscle cells and potential role of magnesium","volume":"10","author":"Louvet","year":"2015","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1161\/HYPERTENSIONAHA.110.152058","article-title":"Vascular smooth muscle cell differentiation to an osteogenic phenotype involves TRPM7 modulation by magnesium","volume":"56","author":"Montezano","year":"2010","journal-title":"Hypertension"},{"key":"B76","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1038\/s41598-018-20241-3","article-title":"Magnesium prevents vascular calcification in vitro by inhibition of hydroxyapatite crystal formation","volume":"8","author":"Ter Braake","year":"2018","journal-title":"Sci Rep"},{"key":"B77","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1097\/HJH.0000000000001202","article-title":"Inhibition of osteo\/chondrogenic transformation of vascular smooth muscle cells by MgCl2 via calcium-sensing receptor","volume":"35","author":"Alesutan","year":"2017","journal-title":"J Hypertens"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1124\/mol.109.058784","article-title":"Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications","volume":"76","author":"Saidak","year":"2009","journal-title":"Mol Pharmacol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e0138833","DOI":"10.1371\/journal.pone.0138833","article-title":"Arterial expression of the calcium-sensing receptor is maintained by physiological pulsation and protects against calcification","volume":"10","author":"Molostvov","year":"2015","journal-title":"PLoS One"},{"key":"B80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/sdi.12653","article-title":"Magnesium supplementation: a consideration in dialysis patients","volume":"31","author":"Apetrii","year":"2018","journal-title":"Semin Dial"},{"key":"B81","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ekir.2016.12.008","article-title":"Oral magnesium supplementation in chronic kidney disease stages 3 and 4: efficacy, safety, and effect on serum calcification propensity-A prospective randomized double-blinded placebo-controlled clinical trial","volume":"2","author":"Bressendorff","year":"2017","journal-title":"Kidney Int Rep"},{"key":"B82","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/01.RES.0000159937.05502.d1","article-title":"Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells","volume":"96","author":"Jaffe","year":"2005","journal-title":"Circ Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1161\/01.ATV.0000258414.59393.89","article-title":"Mineralocorticoid receptor activation promotes vascular cell calcification","volume":"27","author":"Jaffe","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1258\/ebm.2011.011175","article-title":"Endogenous aldosterone is involved in vascular calcification in rat","volume":"237","author":"Wu","year":"2012","journal-title":"Exp Biol Med (Maywood)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000368268","article-title":"Impact of aldosterone on osteoinductive signaling and vascular calcification","volume":"128","author":"Lang","year":"2014","journal-title":"Nephron Physiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1093\/ndt\/gft041","article-title":"Vascular calcification \u2013 is aldosterone a culprit?","volume":"28","author":"Lang","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B87","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1172\/JCI64093","article-title":"Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice","volume":"123","author":"Voelkl","year":"2013","journal-title":"J Clin Invest"},{"key":"B88","doi-asserted-by":"publisher","first-page":"F967","DOI":"10.1152\/ajprenal.00669.2014","article-title":"Spironolactone ameliorates arterial medial calcification in uremic rats: the role of mineralocorticoid receptor signaling in vascular calcification","volume":"309","author":"Tatsumoto","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/emmm.201303716","article-title":"FGF23 regulates renal sodium handling and blood pressure","volume":"6","author":"Andrukhova","year":"2014","journal-title":"EMBO Mol Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1038\/s41598-017-01882-2","article-title":"Involvement of vascular aldosterone synthase in phosphate-induced osteogenic transformation of vascular smooth muscle cells","volume":"7","author":"Alesutan","year":"2017","journal-title":"Sci Rep"},{"key":"B91","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ki.1982.14","article-title":"Plasma aldosterone concentrations in chronic renal disease","volume":"21","author":"Hen\u00e9","year":"1982","journal-title":"Kidney Int"},{"key":"B92","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","article-title":"Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients","volume":"63","author":"Matsumoto","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/S2213-8587(14)70194-9","article-title":"Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial","volume":"2","author":"Ando","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1093\/ndt\/gfq750","article-title":"Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production","volume":"26","author":"Toyonaga","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1006\/jmcc.1999.0963","article-title":"Extra-adrenal mineralocorticoids and cardiovascular tissue","volume":"31","author":"Slight","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1126\/science.3306919","article-title":"Neurosteroids: cytochrome P-450scc in rat brain","volume":"237","author":"Le Goascogne","year":"1987","journal-title":"Science"},{"key":"B97","doi-asserted-by":"publisher","first-page":"5118","DOI":"10.1210\/jc.86.11.5118","article-title":"Editorial: cardiac steroidogenesis \u2013 new sites of synthesis, or much ado about nothing?","volume":"86","author":"Gomez-Sanchez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B98","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1161\/01.HYP.0000175814.18550.c0","article-title":"Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor","volume":"46","author":"Xue","year":"2005","journal-title":"Hypertension"},{"key":"B99","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","article-title":"Vascular aldosterone. Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells","volume":"269","author":"Hatakeyama","year":"1994","journal-title":"J Biol Chem"},{"key":"B100","doi-asserted-by":"publisher","first-page":"15636","DOI":"10.3390\/molecules181215636","article-title":"Vascular aldosterone production at the pre-diabetic stage of young Otsuka Long-Evans Tokushima Fatty (OLETF) rats, compared with Long-Evans Tokushima Otsuka (LETO) rats","volume":"18","author":"Matsuzawa","year":"2013","journal-title":"Molecules"},{"key":"B101","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1161\/01.HYP.29.1.45","article-title":"Vascular aldosterone in genetically hypertensive rats","volume":"29","author":"Takeda","year":"1997","journal-title":"Hypertension"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00109-014-1193-7","article-title":"Mutual amplification of corticosteroids and angiotensin systems in human vascular smooth muscle cells and carotid atheroma","volume":"92","author":"Ayari","year":"2014","journal-title":"J Mol Med (Berl)"},{"key":"B103","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/hr.2009.76","article-title":"The involvement of aldosterone in cyclic stretch-mediated activation of NADPH oxidase in vascular smooth muscle cells","volume":"32","author":"Ohmine","year":"2009","journal-title":"Hypertens Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.3390\/ijms18102053","article-title":"APE1\/Ref-1 inhibits phosphate-induced calcification and osteoblastic phenotype changes in vascular smooth muscle cells","volume":"18","author":"Lee","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B105","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fphys.2015.00269","article-title":"Spironolactone treatment attenuates vascular dysfunction in type 2 diabetic mice by decreasing oxidative stress and restoring NO\/GC signaling","volume":"6","author":"Silva","year":"2015","journal-title":"Front Physiol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/1745-6215-15-160","article-title":"Benefits of aldosterone receptor antagonism in chronic kidney disease (BARACK D) trial-a multi-centre, prospective, randomised, open, blinded end-point, 36-month study of 2,616 patients within primary care with stage 3b chronic kidney disease to compare the efficacy of spironolactone 25 mg once daily in addition to routine care on mortality and cardiovascular outcomes versus routine care alone: study protocol for a randomized controlled trial","volume":"15","author":"Hill","year":"2014","journal-title":"Trials"},{"key":"B107","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1745-6215-15-158","article-title":"Spironolactone to prevent cardiovascular events in early-stage chronic kidney disease (STOP-CKD): study protocol for a randomized controlled pilot trial","volume":"15","author":"Ng","year":"2014","journal-title":"Trials"},{"key":"B108","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1038\/sj.ki.5001854","article-title":"Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease","volume":"70","author":"Bianchi","year":"2006","journal-title":"Kidney Int"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1159\/000323984","article-title":"Induction of metabolic acidosis with ammonium chloride (NH4Cl) in mice and rats \u2013 species differences and technical considerations","volume":"26","author":"Nowik","year":"2010","journal-title":"Cell Physiol Biochem"},{"key":"B110","doi-asserted-by":"publisher","first-page":"e55286","DOI":"10.1371\/journal.pone.0055286","article-title":"Regulation of two renal chloride transporters, AE1 and pendrin, by electrolytes and aldosterone","volume":"8","author":"Mohebbi","year":"2013","journal-title":"PLoS One"},{"key":"B111","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1152\/physrev.1981.61.2.296","article-title":"Intracellular pH","volume":"61","author":"Roos","year":"1981","journal-title":"Physiol Rev"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1046\/j.1523-1755.1998.00952.x","article-title":"Mesangial cell hypertrophy induced by NH4Cl: role of depressed activities of cathepsins due to elevated lysosomal pH","volume":"53","author":"Ling","year":"1998","journal-title":"Kidney Int"},{"key":"B113","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/bj2950011","article-title":"Effect of cell volume on acridine orange fluorescence in hepatocytes","volume":"295","author":"V\u00f6lkl","year":"1993","journal-title":"Biochem J"},{"key":"B114","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/MCO.0b013e328333b829","article-title":"Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity","volume":"13","author":"Haussinger","year":"2010","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"B115","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11011-010-9180-3","article-title":"The Na-K-Cl Co-transporter in astrocyte swelling","volume":"25","author":"Jayakumar","year":"2010","journal-title":"Metab Brain Dis"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s11064-012-0777-2","article-title":"Transporters and channels in cytotoxic astrocyte swelling","volume":"37","author":"Pasantes-Morales","year":"2012","journal-title":"Neurochem Res"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1152\/physrev.00056.2006","article-title":"Cellular response to hyperosmotic stresses","volume":"87","author":"Burg","year":"2007","journal-title":"Physiol Rev"},{"key":"B118","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1159\/000045897","article-title":"Cell and molecular biology of organic osmolyte accumulation in hypertonic renal cells","volume":"87","author":"Handler","year":"2001","journal-title":"Nephron"},{"key":"B119","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1139\/y08-063","article-title":"Lysosomotropic drugs inhibit maturation of transforming growth factor-beta","volume":"86","author":"Basque","year":"2008","journal-title":"Can J Physiol Pharmacol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.jacc.2010.10.054","article-title":"Pleiotropic effects of transforming growth factor-beta1 on pericardial interstitial cells. Implications for fibrosis and calcification in idiopathic constrictive pericarditis","volume":"57","author":"Liu","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1681\/ASN.2010040349","article-title":"Matrix remodeling in vascular calcification associated with chronic kidney disease","volume":"21","author":"Pai","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1089\/ten.tea.2010.0094","article-title":"Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-beta1","volume":"17","author":"Tachi","year":"2011","journal-title":"Tissue Eng Part A"},{"key":"B123","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1681\/ASN.2014030230","article-title":"NH4Cl treatment prevents tissue calcification in klotho deficiency","volume":"26","author":"Leibrock","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1159\/000443411","article-title":"Partial reversal of tissue calcification and extension of life span following ammonium nitrate treatment of klotho-deficient mice","volume":"41","author":"Leibrock","year":"2016","journal-title":"Kidney Blood Press Res"},{"key":"B125","doi-asserted-by":"publisher","first-page":"128","DOI":"10.2174\/1874609811104020128","article-title":"The role of cellular senescence during vascular calcification: a key paradigm in aging research","volume":"4","author":"Mackenzie","year":"2011","journal-title":"Curr Aging Sci"},{"key":"B126","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1161\/CIRCRESAHA.111.261388","article-title":"Aging and atherosclerosis: mechanisms, functional consequences, and potential therapeutics for cellular senescence","volume":"111","author":"Wang","year":"2012","journal-title":"Circ Res"},{"key":"B127","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1474-9726.2006.00199.x","article-title":"Senescence-associated beta-galactosidase is lysosomal beta-galactosidase","volume":"5","author":"Lee","year":"2006","journal-title":"Aging Cell"},{"key":"B128","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1159\/000313831","article-title":"Role of TGF-beta1 in bone matrix production in vascular smooth muscle cells induced by a high-phosphate environment","volume":"115","author":"Wang","year":"2010","journal-title":"Nephron Exp Nephrol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1359\/jbmr.091202","article-title":"BMP-2 and TGF-beta stimulate expression of beta1,3-glucuronosyl transferase 1 (GlcAT-1) in nucleus pulposus cells through AP1, TonEBP, and Sp1: role of MAPKs","volume":"25","author":"Hiyama","year":"2010","journal-title":"J Bone Miner Res"},{"key":"B130","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/cvr\/cvm049","article-title":"Nitric oxide regulates vascular calcification by interfering with TGF-signalling","volume":"77","author":"Kanno","year":"2008","journal-title":"Cardiovasc Res"},{"key":"B131","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1159\/000368524","article-title":"Inhibition of phosphate-induced vascular smooth muscle cell osteo-\/chondrogenic signaling and calcification by bafilomycin A1 and methylamine","volume":"40","author":"Alesutan","year":"2015","journal-title":"Kidney Blood Press Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00207\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T18:54:14Z","timestamp":1661108054000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fendo.2018.00207\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":131,"alternative-id":["10.3389\/fendo.2018.00207"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2018.00207","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"article-number":"207"}}